This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
TORONTO, June 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum ” or the “ Company ”), a biopharmaceutical company focused on advancing innovative...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, June 01, 2026 ...
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
TORONTO, May 18, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum ” or the “ Company ”), a biopharmaceutical company focused on advancing innovative...
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum ” or the “ Company ”), has reported its financial and operational results for...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, April 27, 2026...
TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum BioPharma ”), a biopharmaceutical company dedicated to building a portfolio of...